Switch to:
More From Other Websites
XenoPort to Release Second Quarter Financial Results on August 6, 2014 Jul 22 2014
XenoPort to Release Second Quarter Financial Results on August 6, 2014 Jul 22 2014
Immune Pharma: A Top-Pick Based On Pipeline And Valuation Jul 09 2014
XenoPort entitled to $20M upfront payment on license pact Jun 24 2014
XENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial... Jun 24 2014
XenoPort's XP23829 in Phase II Study Jun 24 2014
XENOPORT INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 16 2014
Stockholders Elect ALL Three XenoPort Director Nominees at Annual Meeting Jun 11 2014
XenoPort to Present at the 2014 Wells Fargo Healthcare Conference Jun 09 2014
XenoPort Urges Stockholders to Vote "FOR ALL" XenoPort Director Nominees on the WHITE Proxy Card Jun 06 2014
CEO Has Special Incentive to Spend on Horizant, Says Clinton Group Jun 05 2014
XenoPort Mails Letter to Stockholders Highlighting ISS’s Recommendation That XenoPort Stockholders... Jun 03 2014
Second Independent Proxy Advisory Firm Recommends that XenoPort Stockholders Vote “FOR ALL”... Jun 02 2014
XenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2014 SLEEP... Jun 02 2014
XenoPort says ISS recommends investors vote for all director nominees May 30 2014
Leading Independent Proxy Advisory Firm ISS Recommends XenoPort Stockholders Vote FOR ALL XenoPort... May 30 2014
Xenoport, Inc. (XNPT) Soars: Stock Up 5.9% May 29 2014
XenoPort to Present at the Jefferies 2014 Global Healthcare Conference May 27 2014
Clinton Group sends letter to XenoPort shareholders May 22 2014
XenoPort Board Ignores Key Issue, Says Clinton Group May 22 2014
XenoPort urges stockholders to vote for all director nominees May 21 2014
XenoPort Files Investor Presentation May 21 2014
Nasdaq stocks posting largest percentage increases May 20 2014
Reckitt Benckiser to develop XenoPort alcohol abuse drug May 15 2014
Reckitt Benckiser to develop XenoPort alcohol abuse drug May 15 2014
XenoPort to Present New Data for Novel Fumarate Analog XP23829 and HORIZANT at the 66th Annual... Apr 24 2014
XenoPort to Present at the Cowen and Company 34th Annual Health Care Conference Feb 24 2014
XenoPort Reports Fourth Quarter and Year-End 2013 Financial Results Feb 20 2014
XenoPort to Present at the RBC Capital Markets' Global Healthcare Conference Feb 18 2014
RLS/WED Survey of Patients' Spouses and Partners Reveals Their Concern of Disease-Related Burdens Feb 13 2014
XenoPort to Release Fourth Quarter and Year-End Financial Results on February 20, 2014 Feb 12 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer Jan 29 2014
XenoPort Announces Pricing of Public Offering of Common Stock Jan 24 2014
XenoPort Announces Proposed Public Offering of Common Stock Jan 21 2014
XenoPort Provides Updates on XP23829 Development and HORIZANT Performance Highlights Jan 12 2014
WED Foundation and XenoPort Announce Preliminary Results from the "Patient Odyssey" Survey Nov 13 2013
XenoPort to Present at the Credit Suisse Healthcare Conference Nov 06 2013
XenoPort to Release Third Quarter Financial Results on November 7 Oct 30 2013


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide